Sat.Apr 22, 2023 - Fri.Apr 28, 2023

article thumbnail

FDA Now Requiring New Warnings For Prescription Opioids

Drug Topics

The FDA is hoping these warnings are a positive step in what will be an extremely long process of ending opioid related deaths.

FDA 187
article thumbnail

How Understanding Risk Factors Can Help Patients With Chronic Diseases Quit Smoking

Drug Topics

How much does education about the specific risks of smoking assist in smoking cessation?

186
186
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: Why involuntary treatment for addiction is a dangerous idea

STAT

As the overdose crisis rages on and the pandemic-fatigued public runs low on empathy, there have been increasing calls for expanded involuntary commitment for people with substance use disorder. Some of the advocacy for more coercive treatment seems rooted in a disdain for people who use drugs, most especially when their drug use occurs visibly and in close geographic proximity to affluence, for example in San Francisco or in the Massachusetts Avenue and Melnea Cass area of Boston which borders

142
142
article thumbnail

World IP Day 2023: Celebrating women leaders in innovation

PhRMA

Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s also a day to reflect on the role Intellectual Property (IP) protections, such as patents, play in supporting the development of cutting-edge technologies.

235
235
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Limitations on Reproductive Rights Makes Agonizing Decisions Even Harder for Pregnant Women With Cancer

Pharmacy Times

Even before the Dobbs ruling overturned country-wide reproductive rights, the oncology field was already facing a dearth of maternal care access challenges.

149
149
article thumbnail

PBMs Are in the Hotseat in Washington DC

Drug Topics

The Senate Finance Committee recently released a framework for legislation, and the leaders of the “big three” PBMs are scheduled to be witnesses at another committee's hearing regarding insulin prices on May 10.

187
187

More Trending

article thumbnail

Three facts about health care spending

PhRMA

There is increasing talk about making changes to our health care system to lower costs for patients and address misaligned incentives. These are important conversations that could lead to meaningful improvements, but only if policymakers take a holistic approach to address all the health care drivers. Far too often, there is a singular focus on prescription medicines, ignoring the other parts of the supply chain that are key drivers of U.S. health care spending.

Insurance 235
article thumbnail

DEA’s Proposed Rules on Controlled Substances Prescribing via Telemedicine and Their Uncertain Impact on the Pharmacy Community

Pharmacy Times

Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.

article thumbnail

Health Care Spending Has Shot Back Up to Pre-Pandemic Levels

Drug Topics

The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.

Insurance 180
article thumbnail

STAT+: Once bullish on digital health, Orexo hits a wall on reimbursement

STAT

After several quarters of promising to deliver concrete progress on key digital therapeutics projects, Swedish pharmaceutical company Orexo on Thursday reported the somber news that its efforts remained stalled. Orexo, which made almost all of its $60 million in 2022 revenues from U.S. sales of Zubsolv, a drug used to treat opioid use disorder, earned negligible income from its three software-based treatments in the first quarter of the year.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Policies need to address the growing threat of antimicrobial resistance

PhRMA

Today, the House Energy & Commerce Subcommittee on Oversight and Investigations will be holding a hearing on the growing public health threat of antimicrobial resistance (AMR). AMR occurs when microorganisms such as bacteria, viruses, fungi and parasites develop the ability to survive against the drugs designed to kill them. Recognized by the World Health Organization (WHO) as “one of the biggest threats to global health, food security and development today,” AMR is a growing crisis that has

211
211
article thumbnail

Despite Lack of Consensus on Definition and Regulations, Digital Therapeutics Are Becoming General Medical Practice

Pharmacy Times

The market for digital therapeutics products is expected to grow given increasing global access to smart technologies, their cost-effectiveness, and the need for patient-specific treatments.

132
132
article thumbnail

FDA Approves Broad Spectrum Parasite Protection for Cats

Drug Topics

The NexGard COMBO topical solution from Boehringer Ingelheim helps protect cats from tapeworms and other intestinal parasites like fleas, ticks, and heartworms.

FDA 187
article thumbnail

Breathing easy: How digital inhalers are changing asthma treatment

Pharmaceutical Technology

AstraZeneca , Teva Pharmaceuticals , and Novartis , and other companies, are expanding their reach in the asthma space by capitalizing on digital technologies to enhance the patient experience. But experts say the complete integration of these devices and platforms into the healthcare system remains to be seen. Dr. Amy Chan, senior clinical research fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

AHIP’s latest misinformation campaign & what it’s trying to hide

PhRMA

If we needed any more proof that the health insurance and pharmacy benefit manager (PBM) industries are one and the same, look no further than a new ad campaign by America’s Health Insurance Plans (AHIP). With PBMs facing increasing scrutiny on Capitol Hill, AHIP is hitting the airwaves to deflect any responsibility for the high cost of medicine many people face.

Insurance 191
article thumbnail

Study Finds Novel CAR T-cell Therapy Feasible, Safe in High-Risk Neuroblastoma

Pharmacy Times

Six weeks after infusion of GD2-CART01, 9 of 27 patients (33%) with relapsed or refractory high-risk neuroblastoma had a complete response or maintained a complete response.

129
129
article thumbnail

The Prevalence Of Long COVID in Vaccinated vs. Unvaccinated Children

Drug Topics

Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.

Vaccines 187
article thumbnail

Led by students, a nascent climate movement is taking hold in medical education

STAT

When Cecilia Sorensen was an emergency medicine resident practicing at Denver Health in Colorado a few years ago, summer was known as “trauma season.” Gunshot and motor vehicle accident victims, people with heart attacks and COPD would stream into the ER. Later, on a fellowship, she witnessed the health impacts of drought in Syria. The common driver, she realized, was climate change and its impact, both locally and globally.

113
113
article thumbnail

Nonprofit hospitals fall short on community benefit, studies show

PhRMA

Nonprofit hospitals are supposed to help provide access to crucial treatment and services in our most vulnerable communities. But recent research adds to the mountain of evidence showing nonprofit hospitals continue to fall short in their community benefit. For example, many nonprofit hospitals participate in the federal 340B Drug Pricing Program, where eligible large nonprofit hospitals can buy deeply discounted 340B medicines and then turn around and charge both uninsured patients and insuranc

Hospitals 185
article thumbnail

FDA Approves Prevnar 20 Vaccine to Prevent Invasive Pneumococcal Disease in Children 6 Weeks Through 17 Years

Pharmacy Times

Prevnar 20 is a next-generation pneumococcal conjugate vaccine that includes capsular polysaccharide conjugates for the 13 serotypes already included in Prevnar 13.

Vaccines 132
article thumbnail

FDA Approves Qalsody, First-of-its-Kind Treatment for Rare Form of ALS

Drug Topics

The drug treats amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS).

FDA 187
article thumbnail

New AI-driven long COVID app coming soon to individual, enterprise customers

Fierce Healthcare

New AI-driven long COVID app coming soon to individual, enterprise customers agliadkovskaya Wed, 04/26/2023 - 14:04

142
142
article thumbnail

STAT Wunderkinds discuss high-impact research, resilience, and social justice

STAT

Elenoe “Crew” Smith used to faint at the sight of blood. Still, she knew from a very young age that she wanted to help people living with sickle cell disease. Now, as a research director at Vertex Pharmaceuticals, she is working on potential sickle cell medicines. Smith was in STAT’s 2017 class of Wunderkinds , an annual selection of standout researchers who are launching their careers.

article thumbnail

Study: New Novel Treatment Increases Frequency of Vaccine Responder for HIV

Pharmacy Times

The analysis, published in Nature Communications, demonstrates glycan trimming also keeps the antibody response away from immunodominant glucan holes and patches.

article thumbnail

FDA Clears Pfizer’s Pneumococcal Conjugate Vaccine for Infants and Children

Drug Topics

Prevnar 20 contains 20 serotypes and grants the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine.

Vaccines 186
article thumbnail

Home care industry touts bipartisan bill to expand Medicare in-home benefits, reimbursement

Fierce Healthcare

Home care industry touts bipartisan bill to expand Medicare in-home benefits, reimbursement dmuoio Mon, 04/24/2023 - 14:08

137
137
article thumbnail

A research team airs the messy truth about AI in medicine — and gives hospitals a guide to fix it

STAT

In public, hospitals rave about artificial intelligence. They trumpet the technology in press releases, plaster its use on billboards, and sprinkle AI into speeches touting its ability to detect diseases earlier and make health care faster, better, and cheaper. But on the front lines, the hype is smashing into a starkly different reality.

Hospitals 109
article thumbnail

Tislelizumab Demonstrates Superior Overall Survival Compared With Chemotherapy

Pharmacy Times

Efficacy and safety data for BeiGene’s therapy shows positive results for individuals with advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

article thumbnail

FDA Clears Wearable Insulin Delivery Device Omnipod GO for Type-2 Diabetes

Drug Topics

Insulet plans to commercialize the new product in the United States starting in 2024.

FDA 187
article thumbnail

Kaiser Permanente to acquire Geisinger Health in bid to launch multi-system VBC platform

Fierce Healthcare

Kaiser Permanente to acquire Geisinger Health in bid to launch multi-system VBC platform dmuoio Wed, 04/26/2023 - 12:49

138
138
article thumbnail

Show 1339: Harnessing the Power of the Vagus Nerve

The People's Pharmacy

We have multiple nervous systems. You are probably aware of the nerves that help move your arms to throw a ball or move your legs to jump. No doubt you also know about the fight-or-flight response triggered by a fright. The oddly named sympathetic nervous system is in charge of that. Many of us don’t pay much attention to the parasympathetic nervous system.

article thumbnail

Expert: Reproductive Rights Legislation Impacts Women’s Medical Options When Diagnosed With Cancer While Pregnant

Pharmacy Times

Limitations on a woman’s options when pregnant and diagnosed with cancer can directly impact her ability to save her own life and preserve her fertility for future pregnancies.

123
123
article thumbnail

Eli Lilly's weight-loss drug passes 2nd trial with flying colors, setting up likely approval

Fierce Pharma

Eli Lilly's weight-loss drug passes 2nd trial with flying colors, setting up likely approval aliu Wed, 04/26/2023 - 22:30

133
133
article thumbnail

The Alliance for Long-Term Care Pharmacy @ Home debuts

Drug Store News

The Alliance for Long-Term Care Pharmacy @ Home is a collaborative effort that aims to improve the care provided to individuals with complex medical needs living in the community.

105
105